Abstract
Cyclic AMP is an ubiquitous molecule that serves as an important second messenger for multiple signaling pathways. At least nine membrane-bound mammalian isoforms of adenylyl cyclase have been identified, and each isoform has a distinct pattern of tissue distribution as well as interaction with regulatory proteins within local cytosolic environment. Adenylyl cyclase is coupled to G-protein receptors and serves to convert ATP to cAMP. Although many of the upstream G-protein receptors and cAMP regulators such as phosphodiesterase have been utilized as targets of pharmacotherapy, the attempt of pharmacologic regulation of adenylyl cyclase itself has not been successful. Recent studies have characterized the distinct physiologic effect of each adenylyl cyclase isoform within different organ systems, suggesting the potential therapeutic utility of isoform-specific regulators of adenylyl cyclase. In the current review, we aim to discuss the effects of genetic regulation for each adenylyl cyclase isoform as well as the development of isoformspecific adenylyl cyclase regulators including their therapeutic potential.
Keywords: cAMP, adenylyl cyclase, P-site inhibitor, forskolin, phosphodiesterase, protein kinase A, G-protein coupled receptor, Epac, adenosine triphosphate, memory loss
Current Enzyme Inhibition
Title:Recent Advance in Isoform-Specific Regulation of Adenylyl Cyclase
Volume: 8 Issue: 2
Author(s): David Wei-Kang Ho, Masanari Umemura, Claudio Bravo and Kousaku Iwatsubo
Affiliation:
Keywords: cAMP, adenylyl cyclase, P-site inhibitor, forskolin, phosphodiesterase, protein kinase A, G-protein coupled receptor, Epac, adenosine triphosphate, memory loss
Abstract: Cyclic AMP is an ubiquitous molecule that serves as an important second messenger for multiple signaling pathways. At least nine membrane-bound mammalian isoforms of adenylyl cyclase have been identified, and each isoform has a distinct pattern of tissue distribution as well as interaction with regulatory proteins within local cytosolic environment. Adenylyl cyclase is coupled to G-protein receptors and serves to convert ATP to cAMP. Although many of the upstream G-protein receptors and cAMP regulators such as phosphodiesterase have been utilized as targets of pharmacotherapy, the attempt of pharmacologic regulation of adenylyl cyclase itself has not been successful. Recent studies have characterized the distinct physiologic effect of each adenylyl cyclase isoform within different organ systems, suggesting the potential therapeutic utility of isoform-specific regulators of adenylyl cyclase. In the current review, we aim to discuss the effects of genetic regulation for each adenylyl cyclase isoform as well as the development of isoformspecific adenylyl cyclase regulators including their therapeutic potential.
Export Options
About this article
Cite this article as:
Wei-Kang Ho David, Umemura Masanari, Bravo Claudio and Iwatsubo Kousaku, Recent Advance in Isoform-Specific Regulation of Adenylyl Cyclase, Current Enzyme Inhibition 2012; 8 (2) . https://dx.doi.org/10.2174/157340812800793282
DOI https://dx.doi.org/10.2174/157340812800793282 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pleiotropic Effect of Statins as Antioxidants on Cardiac Hypertrophy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine Mechanical Circulatory Support of the Critically Ill Child Awaiting Heart Transplantation
Current Cardiology Reviews Trypanosomatid Parasites Causing Neglected Diseases
Current Medicinal Chemistry Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Implications In Anesthesia Practice
Current Pharmaceutical Design Patent Selections :
Recent Patents on Cardiovascular Drug Discovery Taurine, Bone Growth and Bone Development
Current Nutrition & Food Science The Role of Transesophageal Echocardiography in the Intraoperative Period
Current Cardiology Reviews Advances in Drug Discovery against Neglected Tropical Diseases: Human African and American Trypanosomiasis
Current Medicinal Chemistry Molecular Diagnosis and Treatment of Multiple Endocrine Neoplasia Type 2B in Ethnic Han Chinese
Endocrine, Metabolic & Immune Disorders - Drug Targets Acetylome Regulation by Sirtuins in the Brain: From Normal Physiology to Aging and Pathology
Current Pharmaceutical Design Cardiac Gene Therapy: Therapeutic Potential and Current Progress
Current Gene Therapy Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?
Current Cardiology Reviews The Role of Obesity in Cardiomyopathy and Nephropathy
Current Pharmaceutical Design Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)
Current Gene Therapy RNAi-based Gene Therapy for Dominant Limb Girdle Muscular Dystrophies
Current Gene Therapy Challenges in Chagas Disease Drug Discovery: A Review
Current Medicinal Chemistry L-Arginine Availability as a Pathological Mechanism in Essential Hypertension, Chronic Renal and Heart Failure
Vascular Disease Prevention (Discontinued) Surgical Ventricular Restoration to Reverse Left Ventricular Remodeling
Current Cardiology Reviews Fatty Liver and Ischemia/Reperfusion: Are there Drugs Able to Mitigate Injury?
Current Medicinal Chemistry